Selected research
Industry Research
Surgical Ablation Industry Research Report 2026
Market perspective
The global Surgical Ablation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Surgical Ablation market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Surgical Ablation market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Surgical Ablation market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Surgical Ablation include AngioDynamics, Boston Scientific Corporation, Johnson & Johnson, Medtronic, AtriCure, olympus Corporation, Smith & Nephew, Minerva Surgical and Merit Medical Systems and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Surgical Ablation market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Surgical Ablation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Surgical Ablation Market by Company
AngioDynamics
Boston Scientific Corporation
Johnson & Johnson
Medtronic
AtriCure
olympus Corporation
Smith & Nephew
Minerva Surgical
Merit Medical Systems
Biotronik SE &Co.KG
Surgical Ablation Segment by Type
Radiofrequency Ablation
Laser Ablation
Electroablation
Cryoablation
Ultrasound Ablation
Other
Surgical Ablation Segment by Application
Oncology
Cardiovascular Department
Orthopaedics
Gastroenterology
Other
Surgical Ablation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Surgical Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Surgical Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Surgical Ablation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Surgical Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Radiofrequency Ablation
- Laser Ablation
- Electroablation
- Cryoablation
- Ultrasound Ablation
- Other
Applications
- Oncology
- Cardiovascular Department
- Orthopaedics
- Gastroenterology
- Other
Companies covered
- AngioDynamics
- Boston Scientific Corporation
- Johnson & Johnson
- Medtronic
- AtriCure
- olympus Corporation
- Smith & Nephew
- Minerva Surgical
- Merit Medical Systems
- Biotronik SE &Co.KG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Surgical Ablation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Radiofrequency Ablation
- 2.2.3 Laser Ablation
- 2.2.4 Electroablation
- 2.2.5 Cryoablation
- 2.2.6 Ultrasound Ablation
- 2.2.7 Other
- 2.3 Surgical Ablation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Oncology
- 2.3.3 Cardiovascular Department
- 2.3.4 Orthopaedics
- 2.3.5 Gastroenterology
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Surgical Ablation Breakdown Data by Type
- 3.1 Global Surgical Ablation Historic Market Size by Type (2021-2026)
- 3.2 Global Surgical Ablation Forecasted Market Size by Type (2027-2032)
4 Surgical Ablation Breakdown Data by Application
- 4.1 Global Surgical Ablation Historic Market Size by Application (2021-2026)
- 4.2 Global Surgical Ablation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Surgical Ablation Market Perspective (2021-2032)
- 5.2 Global Surgical Ablation Growth Trends by Region
- 5.2.1 Global Surgical Ablation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Surgical Ablation Historic Market Size by Region (2021-2026)
- 5.2.3 Surgical Ablation Forecasted Market Size by Region (2027-2032)
- 5.3 Surgical Ablation Market Dynamics
- 5.3.1 Surgical Ablation Industry Trends
- 5.3.2 Surgical Ablation Market Drivers
- 5.3.3 Surgical Ablation Market Challenges
- 5.3.4 Surgical Ablation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Surgical Ablation Players by Revenue
- 6.1.1 Global Top Surgical Ablation Players by Revenue (2021-2026)
- 6.1.2 Global Surgical Ablation Revenue Market Share by Players (2021-2026)
- 6.2 Global Surgical Ablation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Surgical Ablation Head Office and Area Served
- 6.4 Global Surgical Ablation Players, Product Type & Application
- 6.5 Global Surgical Ablation Manufacturers Established Date
- 6.6 Global Surgical Ablation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Surgical Ablation Market Size (2021-2032)
- 7.2 North America Surgical Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Surgical Ablation Market Size by Country (2021-2026)
- 7.4 North America Surgical Ablation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Surgical Ablation Market Size (2021-2032)
- 8.2 Europe Surgical Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Surgical Ablation Market Size by Country (2021-2026)
- 8.4 Europe Surgical Ablation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Surgical Ablation Market Size (2021-2032)
- 9.2 Asia-Pacific Surgical Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Surgical Ablation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Surgical Ablation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Surgical Ablation Market Size (2021-2032)
- 10.2 South America Surgical Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Surgical Ablation Market Size by Country (2021-2026)
- 10.4 South America Surgical Ablation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Surgical Ablation Market Size (2021-2032)
- 11.2 Middle East & Africa Surgical Ablation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Surgical Ablation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Surgical Ablation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AngioDynamics
- 12.1.1 AngioDynamics Company Information
- 12.1.2 AngioDynamics Business Overview
- 12.1.3 AngioDynamics Revenue in Surgical Ablation Business (2021-2026)
- 12.1.4 AngioDynamics Surgical Ablation Product Portfolio
- 12.1.5 AngioDynamics Recent Developments
- 12.2 Boston Scientific Corporation
- 12.2.1 Boston Scientific Corporation Company Information
- 12.2.2 Boston Scientific Corporation Business Overview
- 12.2.3 Boston Scientific Corporation Revenue in Surgical Ablation Business (2021-2026)
- 12.2.4 Boston Scientific Corporation Surgical Ablation Product Portfolio
- 12.2.5 Boston Scientific Corporation Recent Developments
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Company Information
- 12.3.2 Johnson & Johnson Business Overview
- 12.3.3 Johnson & Johnson Revenue in Surgical Ablation Business (2021-2026)
- 12.3.4 Johnson & Johnson Surgical Ablation Product Portfolio
- 12.3.5 Johnson & Johnson Recent Developments
- 12.4 Medtronic
- 12.4.1 Medtronic Company Information
- 12.4.2 Medtronic Business Overview
- 12.4.3 Medtronic Revenue in Surgical Ablation Business (2021-2026)
- 12.4.4 Medtronic Surgical Ablation Product Portfolio
- 12.4.5 Medtronic Recent Developments
- 12.5 AtriCure
- 12.5.1 AtriCure Company Information
- 12.5.2 AtriCure Business Overview
- 12.5.3 AtriCure Revenue in Surgical Ablation Business (2021-2026)
- 12.5.4 AtriCure Surgical Ablation Product Portfolio
- 12.5.5 AtriCure Recent Developments
- 12.6 olympus Corporation
- 12.6.1 olympus Corporation Company Information
- 12.6.2 olympus Corporation Business Overview
- 12.6.3 olympus Corporation Revenue in Surgical Ablation Business (2021-2026)
- 12.6.4 olympus Corporation Surgical Ablation Product Portfolio
- 12.6.5 olympus Corporation Recent Developments
- 12.7 Smith & Nephew
- 12.7.1 Smith & Nephew Company Information
- 12.7.2 Smith & Nephew Business Overview
- 12.7.3 Smith & Nephew Revenue in Surgical Ablation Business (2021-2026)
- 12.7.4 Smith & Nephew Surgical Ablation Product Portfolio
- 12.7.5 Smith & Nephew Recent Developments
- 12.8 Minerva Surgical
- 12.8.1 Minerva Surgical Company Information
- 12.8.2 Minerva Surgical Business Overview
- 12.8.3 Minerva Surgical Revenue in Surgical Ablation Business (2021-2026)
- 12.8.4 Minerva Surgical Surgical Ablation Product Portfolio
- 12.8.5 Minerva Surgical Recent Developments
- 12.9 Merit Medical Systems
- 12.9.1 Merit Medical Systems Company Information
- 12.9.2 Merit Medical Systems Business Overview
- 12.9.3 Merit Medical Systems Revenue in Surgical Ablation Business (2021-2026)
- 12.9.4 Merit Medical Systems Surgical Ablation Product Portfolio
- 12.9.5 Merit Medical Systems Recent Developments
- 12.10 Biotronik SE &Co.KG
- 12.10.1 Biotronik SE &Co.KG Company Information
- 12.10.2 Biotronik SE &Co.KG Business Overview
- 12.10.3 Biotronik SE &Co.KG Revenue in Surgical Ablation Business (2021-2026)
- 12.10.4 Biotronik SE &Co.KG Surgical Ablation Product Portfolio
- 12.10.5 Biotronik SE &Co.KG Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst